Statistics for Jasper Therapeutics, (id:5802 JSPR)

Valuation metrics

Market cap

330.78M

Enterprise value

237.20M

Trailing P/E (ttm)

-3.57

Forward P/E

-4.88

PEG ratio

-4.88

Price/Sales (ttm)

Price/Book (mrq)

3.95

Enterprise Value/Revenue

Enterprise Value/EBITDA

-3.53

Overview

Shares outstanding

15.00M

Float

9.28M

Shares short

1.76M

% Held by insiders

0.05%

% Held by institutions

1.00%

Average volume (10 days)

212.32K

Average volume (90 days)

Price summary

52-Week low

4.00

52-Week high

31.01

52-Week change

70.20%

Beta

2.20

50-Day moving average

20.28

200-Day moving average

21.79

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

January 04th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-40.92%

Return on equity

-71.46%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-67,268,000.00

Net income to common (ttm)

-63,529,000.00

Diluted EPS (ttm)

-4.75

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

92.50M

Total cash per share (mrq)

6.17

Total debt (mrq)

2.07M

Total Debt/Equity (mrq)

2.47

Current ratio (mrq)

760.90%

Book value per share (mrq)

5.58

Cash flow

Cash flow statement

-57,947,000.00

Levered free cash flow (LFCF)

-36,906,376.00